Immunogenicity and protective efficacy of OmpA subunit vaccine against Aeromonas hydrophila infection in Megalobrama amblycephala: An effective alternative to the inactivated vaccine

被引:8
|
作者
Zhang, Minying [1 ]
Zhang, Ting [1 ]
He, Yang [2 ]
Cui, Hujun [1 ,3 ]
Li, Hong [4 ]
Xu, Zehua [1 ]
Wang, Xu [1 ]
Liu, Yunlong [1 ]
Li, Hongping [1 ]
Zhao, Xiaoheng [1 ,3 ]
Cheng, Hanliang [1 ,3 ]
Xu, Jianhe [1 ,3 ]
Chen, Xiangning [1 ,3 ]
Ding, Zhujin [1 ,3 ]
机构
[1] Jiangsu Ocean Univ, Coll Marine Life & Fisheries, Coinnovat Ctr Jiangsu Marine Bioind Technol, Jiangsu Key Lab Marine Biotechnol, Lianyungang, Peoples R China
[2] Neijiang Normal Univ, Key Lab Sichuan Prov Fishes Conservat & Utilizat U, Neijiang, Peoples R China
[3] Jiangsu Inst Marine Resources Dev, Lianyungang, Peoples R China
[4] Hunan Fisheries Sci Inst, Changsha, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
Aeromonas hydrophila; inactivated vaccine; OmpA subunit vaccine; immunogenicity; Immunoprotection; OUTER-MEMBRANE PROTEINS; IMMUNE-RESPONSE; EXPRESSION ANALYSIS; MOLECULAR-CLONING; GENE-EXPRESSION; CLASS-I; IDENTIFICATION; CANDIDATE; ANTIGENS; VIRUS;
D O I
10.3389/fimmu.2023.1133742
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aeromonas hydrophila is a kind of zoonotic pathogen, which can cause bacterial septicemia in fish and bring huge economic losses to global aquaculture. Outer membrane proteins (Omps) are conserved antigens of Aeromonas hydrophila, which can be developed as subunit vaccines. To evaluate the protective efficacy of inactivated vaccine and recombinant outer membrane protein A (OmpA) subunit vaccine against A. hydrophila in juvenile Megalobrama amblycephala, the present study investigated the immunogenicity and protective effects of both vaccines, as well as the non-specific and specific immune response of M. amblycephala. Compared with the non-vaccinated group, both inactivated and OmpA subunit vaccines improved the survival rate of M. amblycephala upon infection. The protective effects of OmpA vaccine groups were better than that of the inactivated vaccine groups, which should be attributed to the reduced bacterial load and enhanced host immunity in the vaccinated fish. ELISA assay showed that the titer of serum immunoglobulin M (IgM) specific to A. hydrophila up-regulated significantly in the OmpA subunit vaccine groups at 14 d post infection (dpi), which should contribute to better immune protective effects. In addition, vaccination enhanced host bactericidal abilities might also attribute to the regulation of the activities of hepatic and serum antimicrobial enzymes. Moreover, the expression of immune-related genes (SAA, iNOS, IL-1 beta, IL-6, IL-10, TNF alpha, C3, MHC I, MHC II, CD4, CD8, TCR alpha, IgM, IgD and IgZ) increased in all groups post infection, which was more significant in the vaccinated groups. Furthermore, the number of immunopositive cells exhibiting different epitopes (CD8, IgM, IgD and IgZ) that were detected by immunohistochemical assay had increased in the vaccinated groups post infection. These results show that vaccination effectively stimulated host immune response (especially OmpA vaccine groups). In conclusion, these results indicated that both the inactivated vaccine and OmpA subunit vaccine could protect juvenile M. amblycephala against A. hydrophila infection, of which OmpA subunit vaccine provided more effective immune protection and can be used as an ideal candidate for the A. hydrophila vaccine.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Immunogenicity and protective efficacy of an inactivated infectious bronchitis virus vaccine candidate from a local isolate of Bangladesh
    Parvin, Mst. Kohinoor
    Haque, Md. Enamul
    Haque, Mohammad Aynul
    Kamal, Md. Mostofa
    Sadekuzzaman, Mohammad
    Hayat, Sajedul
    Rahman, Md. Tanvir
    Siddique, Mahbubul Pratik
    Nahar, Sham Soun
    Khasruzzaman, A. K. M.
    Hossain, Muhammad Tofazzal
    Islam, Md. Alimul
    JOURNAL OF ADVANCED VETERINARY AND ANIMAL RESEARCH, 2024, 11 (03) : 592 - 600
  • [42] Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
    Hao, Ling
    Wu, Yaqi
    Zhang, Yandi
    Zhou, Zijie
    Lei, Qing
    Ullah, Nadeem
    Ndzouboukou, Jo-Lewis Banga
    Lin, Xiaosong
    Fan, Xionglin
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [43] Efficacy of a recombinant Lactobacillus plantarum Lp-pPG-Malt as an oral vaccine candidate against Aeromonas hydrophila infection in crucian carp
    Yang, Qing
    Yang, Bin-Tong
    Kang, Yuan-Huan
    Cong, Wei
    FISH & SHELLFISH IMMUNOLOGY, 2023, 136
  • [44] Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
    Govindarajan, Dhanasekaran
    Meschino, Steven
    Guan, Liming
    Clements, David E.
    ter Meulenc, Jan H.
    Casimiro, Danilo R.
    Collera, Beth-Ann G.
    Bett, Andrew J.
    VACCINE, 2015, 33 (33) : 4105 - 4116
  • [45] Development of a protective inactivated vaccine against Crimean-Congo hemorrhagic fever infection
    Berber, Engin
    Canakoglu, Nurettin
    Tonbak, Sukru
    Ozdarendeli, Aykut
    HELIYON, 2022, 7 (10)
  • [46] The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice
    Cataldo, DM
    VanNest, G
    VACCINE, 1997, 15 (16) : 1710 - 1715
  • [47] Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies
    Kozlovskaya, Liubov, I
    Piniaeva, Anastasia N.
    Ignatyev, Georgy M.
    Gordeychuk, Ilya, V
    Volok, Viktor P.
    Rogova, Yulia, V
    Shishova, Anna A.
    Kovpak, Anastasia A.
    Ivin, Yury Yu
    Antonova, Liliya P.
    Mefyod, Kirill M.
    Prokosheva, Lyubov S.
    Sibirkina, Anna S.
    Tarasova, Yuliya Yu
    Bayurova, Ekaterina O.
    Gancharova, Olga S.
    Illarionova, Victoria V.
    Glukhov, Grigory S.
    Sokolova, Olga S.
    Shaitan, Konstantin, V
    Moysenovich, Anastasia M.
    Gulyaev, Stanislav A.
    Gulyaeva, Tatiana, V
    Moroz, Andrey, V
    Gmyl, Larissa, V
    Ipatova, Elena G.
    Kirpichnikov, Mikhail P.
    Egorov, Alexey M.
    Siniugina, Aleksandra A.
    Ishmukhametov, Aydar A.
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1790 - 1806
  • [48] Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates
    Yan-Feng Yao
    Ze-Jun Wang
    Ren-Di Jiang
    Xue Hu
    Hua-Jun Zhang
    Yi-Wu Zhou
    Ge Gao
    Ying Chen
    Yun Peng
    Mei-Qin Liu
    Ya-Nan Zhang
    Juan Min
    Jia Lu
    Xiao-Xiao Gao
    Jing Guo
    Cheng Peng
    Xu-Rui Shen
    Qian Li
    Kai Zhao
    Lian Yang
    Xin Wan
    Bo Zhang
    Wen-Hui Wang
    Jia Wu
    Peng Zhou
    Xing-Lou Yang
    Shuo Shen
    Chao Shan
    Zhi-Ming Yuan
    Zheng-Li Shi
    Virologica Sinica, 2021, 36 (05) : 879 - 889
  • [49] Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model
    Kumar, Ramesh
    Bera, Bidhan Chandra
    Anand, Taruna
    Pavulraj, Selvaraj
    Mathew, Manu Kurian
    Gupta, R. P.
    Tripathi, Bhupendra Nath
    Virmani, Nitin
    VETERINARY RESEARCH COMMUNICATIONS, 2024, 48 (03) : 1707 - 1726
  • [50] Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates
    Yao, Yan-Feng
    Wang, Ze-Jun
    Jiang, Ren-Di
    Hu, Xue
    Zhang, Hua-Jun
    Zhou, Yi-Wu
    Gao, Ge
    Chen, Ying
    Peng, Yun
    Liu, Mei-Qin
    Zhang, Ya-Nan
    Min, Juan
    Lu, Jia
    Gao, Xiao-Xiao
    Guo, Jing
    Peng, Cheng
    Shen, Xu-Rui
    Li, Qian
    Zhao, Kai
    Yang, Lian
    Wan, Xin
    Zhang, Bo
    Wang, Wen-Hui
    Wu, Jia
    Zhou, Peng
    Yang, Xing-Lou
    Shen, Shuo
    Shan, Chao
    Yuan, Zhi-Ming
    Shi, Zheng-Li
    VIROLOGICA SINICA, 2021, 36 (05) : 879 - 889